Latest Insider Transactions at Centene Corp (CNC)
This section provides a real-time view of insider transactions for Centene Corp (CNC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CENTENE CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CENTENE CORP's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2021
|
John R Roberts Director |
BUY
Grant, award, or other acquisition
|
Direct |
467
+0.22%
|
$30,822
$66.82 P/Share
|
|
Sep 14
2021
|
Sarah London Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,844
-1.78%
|
$238,328
$62.9 P/Share
|
|
Sep 07
2021
|
Sarah London Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
110,000
+33.71%
|
$7,040,000
$64.37 P/Share
|
|
Sep 07
2021
|
Brent D Layton President & COO |
BUY
Grant, award, or other acquisition
|
Direct |
110,000
+17.08%
|
$7,040,000
$64.37 P/Share
|
|
Aug 31
2021
|
Michael F Neidorff Chairman & CEO |
SELL
Bona fide gift
|
Direct |
79,598
-1.2%
|
-
|
|
Aug 02
2021
|
Brent D Layton President & COO |
SELL
Bona fide gift
|
Direct |
2,500
-0.59%
|
-
|
|
Jul 29
2021
|
Brent D Layton President & COO |
SELL
Open market or private sale
|
Direct |
4,000
-0.93%
|
$280,000
$70.0 P/Share
|
|
Jul 29
2021
|
Orlando Ayala Director |
SELL
Open market or private sale
|
Direct |
9,366
-9.34%
|
$655,620
$70.0 P/Share
|
|
Jul 06
2021
|
David P Thomas CEO, Markets and Medicaid |
SELL
Payment of exercise price or tax liability
|
Direct |
4,131
-5.15%
|
$301,563
$73.88 P/Share
|
|
Jul 01
2021
|
David P Thomas CEO, Markets and Medicaid |
SELL
Payment of exercise price or tax liability
|
Direct |
1,414
-1.73%
|
$101,808
$72.93 P/Share
|
|
Jun 30
2021
|
H James Dallas Director |
BUY
Grant, award, or other acquisition
|
Direct |
456
+1.73%
|
$31,008
$68.51 P/Share
|
|
Jun 30
2021
|
Robert K Ditmore Director |
BUY
Grant, award, or other acquisition
|
Direct |
620
+0.09%
|
$42,160
$68.51 P/Share
|
|
Jun 30
2021
|
David L Steward Director |
BUY
Grant, award, or other acquisition
|
Direct |
510
+0.23%
|
$34,680
$68.51 P/Share
|
|
Jun 30
2021
|
Frederick H Eppinger Director |
BUY
Grant, award, or other acquisition
|
Direct |
456
+0.14%
|
$31,008
$68.51 P/Share
|
|
Jun 30
2021
|
William L Trubeck Director |
BUY
Grant, award, or other acquisition
|
Direct |
456
+0.5%
|
$31,008
$68.51 P/Share
|
|
Jun 30
2021
|
Tommy G Thompson Director |
BUY
Grant, award, or other acquisition
|
Direct |
510
+0.22%
|
$34,680
$68.51 P/Share
|
|
Jun 30
2021
|
John R Roberts Director |
BUY
Grant, award, or other acquisition
|
Direct |
456
+0.21%
|
$31,008
$68.51 P/Share
|
|
Jun 23
2021
|
Brent D Layton President & COO |
BUY
Grant, award, or other acquisition
|
Direct |
13,500
+3.04%
|
$972,000
$72.2 P/Share
|
|
Jun 23
2021
|
Christopher Koster Secretary & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
13,500
+9.09%
|
$972,000
$72.2 P/Share
|
|
Jun 23
2021
|
Sarah London Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,500
+11.26%
|
$972,000
$72.2 P/Share
|
|
Jun 21
2021
|
Brandy Burkhalter EVP |
SELL
Payment of exercise price or tax liability
|
Direct |
2,238
-0.59%
|
$158,898
$71.69 P/Share
|
|
Jun 18
2021
|
John R Roberts Director |
BUY
Bona fide gift
|
Indirect |
13,550
+8.7%
|
-
|
|
Jun 18
2021
|
John R Roberts Director |
SELL
Bona fide gift
|
Indirect |
13,550
-88.05%
|
-
|
|
Jun 15
2021
|
Orlando Ayala Director |
SELL
Open market or private sale
|
Direct |
30,000
-23.03%
|
$2,070,000
$69.01 P/Share
|
|
Jun 11
2021
|
Jesse N Hunter EVP, M&A & Chief Strategy Ofcr |
SELL
Open market or private sale
|
Direct |
25,000
-5.72%
|
$1,775,000
$71.17 P/Share
|
|
May 27
2021
|
John R Roberts Director |
BUY
Bona fide gift
|
Indirect |
6,510
+29.73%
|
-
|
|
May 27
2021
|
John R Roberts Director |
SELL
Bona fide gift
|
Indirect |
6,510
-4.81%
|
-
|
|
May 12
2021
|
Michael F Neidorff Chairman & CEO |
SELL
Bona fide gift
|
Direct |
50
-0.0%
|
-
|
|
May 07
2021
|
Jeffrey A. Schwaneke EVP, HealthCare Enterprises |
SELL
Open market or private sale
|
Direct |
18,000
-3.81%
|
$1,242,000
$69.0 P/Share
|
|
May 07
2021
|
Andrew Lynn Asher Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+17.6%
|
$3,250,000
$65.19 P/Share
|
|
May 07
2021
|
Mark J Brooks EVP, Chief Information Officer |
SELL
Open market or private sale
|
Direct |
15,000
-8.36%
|
$1,020,000
$68.0 P/Share
|
|
May 07
2021
|
John R Roberts Director |
SELL
Open market or private sale
|
Indirect |
5,000
-36.03%
|
$350,000
$70.0 P/Share
|
|
May 06
2021
|
John R Roberts Director |
BUY
Bona fide gift
|
Indirect |
3,300
+37.08%
|
-
|
|
May 06
2021
|
John R Roberts Director |
SELL
Bona fide gift
|
Direct |
3,300
-1.52%
|
-
|
|
May 05
2021
|
Brent D Layton President & COO |
SELL
Open market or private sale
|
Direct |
7,682
-1.81%
|
$499,330
$65.0 P/Share
|
|
Apr 29
2021
|
Orlando Ayala Director |
SELL
Open market or private sale
|
Direct |
7,201
-5.24%
|
$432,060
$60.0 P/Share
|
|
Apr 29
2021
|
Michael F Neidorff Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
14,166
+0.11%
|
$623,304
$44.07 P/Share
|
|
Apr 27
2021
|
Christopher Koster Secretary & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
11,188
-8.43%
|
$738,408
$66.0 P/Share
|
|
Apr 27
2021
|
Orlando Ayala Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,300
+2.34%
|
$217,800
$66.0 P/Share
|
|
Apr 27
2021
|
Jessica L. Blume Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,300
+16.58%
|
$217,800
$66.0 P/Share
|
|
Apr 27
2021
|
H James Dallas Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,300
+11.5%
|
$217,800
$66.0 P/Share
|
|
Apr 27
2021
|
Robert K Ditmore Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,300
+0.49%
|
$217,800
$66.0 P/Share
|
|
Apr 27
2021
|
Frederick H Eppinger Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,300
+0.98%
|
$217,800
$66.0 P/Share
|
|
Apr 27
2021
|
Richard A Gephardt Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,300
+5.0%
|
$217,800
$66.0 P/Share
|
|
Apr 27
2021
|
Lori Jean Robinson Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,300
+27.31%
|
$217,800
$66.0 P/Share
|
|
Apr 27
2021
|
David L Steward Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,300
+1.49%
|
$217,800
$66.0 P/Share
|
|
Apr 27
2021
|
Tommy G Thompson Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,300
+1.44%
|
$217,800
$66.0 P/Share
|
|
Apr 27
2021
|
William L Trubeck Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,300
+3.5%
|
$217,800
$66.0 P/Share
|
|
Apr 27
2021
|
John R Roberts Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,300
+1.5%
|
$217,800
$66.0 P/Share
|
|
Apr 15
2021
|
Brent D Layton President & COO |
SELL
Bona fide gift
|
Direct |
795
-0.19%
|
-
|